來源：學(xué)術(shù)之家整理 2025-03-18 15:40:41
《Journal For Immunotherapy Of Cancer》中文名稱：《癌癥免疫治療雜志》，創(chuàng)刊于2013年，由BioMed Central出版商出版，出版周期1 issue/year。
《癌癥免疫治療雜志》（JITC）是一本開放獲取、同行評審的期刊，涵蓋了腫瘤免疫學(xué)和癌癥免疫治療的各個方面，從基礎(chǔ)研究到臨床應(yīng)用。
旨在及時、準(zhǔn)確、全面地報道國內(nèi)外IMMUNOLOGY工作者在該領(lǐng)域的科學(xué)研究等工作中取得的經(jīng)驗、科研成果、技術(shù)革新、學(xué)術(shù)動態(tài)等。
| 機(jī)構(gòu)名稱 | 發(fā)文量 |
| UNIVERSITY OF TEXAS SYS... | 270 |
| HARVARD UNIVERSITY | 203 |
| UNIVERSITY OF CALIFORNI... | 144 |
| PENNSYLVANIA COMMONWEAL... | 115 |
| DANA-FARBER CANCER INST... | 114 |
| MEMORIAL SLOAN KETTERIN... | 111 |
| JOHNS HOPKINS UNIVERSIT... | 108 |
| MASSACHUSETTS GENERAL H... | 80 |
| UNICANCER | 79 |
| YALE UNIVERSITY | 79 |
| 國家/地區(qū) | 發(fā)文量 |
| USA | 2013 |
| GERMANY (FED REP GER) | 244 |
| CHINA MAINLAND | 243 |
| France | 193 |
| England | 186 |
| Italy | 134 |
| Canada | 124 |
| Switzerland | 116 |
| Netherlands | 115 |
| Spain | 98 |
| 文章引用名稱 | 引用次數(shù) |
| Cytokine release syndrome | 246 |
| Development of PD-1 and PD-L... | 176 |
| Targeting adenosine for canc... | 81 |
| Immune-related adverse event... | 68 |
| A systematic review of the c... | 63 |
| The role of PD-L1 expression... | 62 |
| A multicenter study of body ... | 58 |
| Current landscape and future... | 56 |
| The Society for Immunotherap... | 55 |
| Updated efficacy of avelumab... | 53 |
| 被引用期刊名稱 | 數(shù)量 |
| J IMMUNOTHER CANCER | 259 |
| FRONT IMMUNOL | 177 |
| CANCERS | 168 |
| INT J MOL SCI | 83 |
| FRONT ONCOL | 82 |
| CLIN CANCER RES | 72 |
| ONCOIMMUNOLOGY | 63 |
| IMMUNOTHERAPY-UK | 54 |
| EUR J CANCER | 44 |
| CANCER IMMUNOL IMMUN | 39 |
| 引用期刊名稱 | 數(shù)量 |
| J CLIN ONCOL | 651 |
| NEW ENGL J MED | 638 |
| CLIN CANCER RES | 597 |
| CANCER RES | 463 |
| J IMMUNOL | 419 |
| NATURE | 407 |
| SCIENCE | 347 |
| BLOOD | 304 |
| P NATL ACAD SCI USA | 264 |
| J IMMUNOTHER CANCER | 259 |
聲明：該作品系作者結(jié)合互聯(lián)網(wǎng)公開知識整合。如有錯漏請聯(lián)系我們，我們將及時更正。
